Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERAP2 | Q6P179 | 8/20 | 0.76 |
| ▸ | ECE1 | P42892 | 7/20 | 0.66 |
| ▸ | ACE | P12821 | 2/20 | 0.62 |
| ▸ | IL1RN | P18510 | 6/20 | 0.61 |
| ▸ | ERAP1 | Q9NZ08 | 5/20 | 0.61 |
| ▸ | ANPEP | P15144 | 1/20 | 0.58 |
| ▸ | MMP1 | P03956 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31042843 | 0.94 | ERAP2 (0.73) | ERAP2ECE1ACEIL1RNERAP1 | |
| SCHEMBL29816206 | 0.94 | ERAP2 (0.67) | ERAP2ECE1ACEIL1RNERAP1 | |
| SCHEMBL30004587 | 0.93 | ERAP2 (0.67) | ERAP2ECE1ACEIL1RNERAP1 | |
| SCHEMBL31074338 | 0.93 | ERAP2 (0.67) | ERAP2ECE1ACEIL1RNERAP1 | |
| SCHEMBL30839328 | 0.93 | ERAP2 (0.73) | ERAP2ECE1ACEIL1RNERAP1 | |
| SCHEMBL30051190 | 0.92 | ECE1 (0.74) | ERAP2ECE1ACEIL1RNERAP1 | |
| SCHEMBL14940856 | 0.92 | ECE1 (0.77) | ERAP2ECE1ACEERAP1ANPEP | |
| SCHEMBL29531224 | 0.92 | ECE1 (0.77) | ERAP2ECE1ACEERAP1ANPEP | |
| SCHEMBL11589639 | 0.92 | ECE1 (0.77) | ERAP2ECE1ACEERAP1ANPEP | |
| SCHEMBL29448679 | 0.92 | ECE1 (0.77) | ERAP2ECE1ACEERAP1ANPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110437336-B | Proteins specific for BAFF and B7RP1 and uses thereof | 美国安进公司 | 2024-08-27 | — | — | CN | disclosed |
| EP-4370150-A1 | OVERCOMING ANTIBODY-INTERFERENCE IN AVIANS | Intervet International B.V. (NL) | 2024-05-22 | — | — | EP | disclosed |
| US-20230212297-A1 | BISPECIFIC FC MOLECULES | AMGEN INC. | 2023-07-06 | — | — | US | disclosed |
| WO-2023285489-A1 | OVERCOMING ANTIBODY-INTERFERENCE IN AVIANS | INTERVET INTERNATIONAL B.V. (NL) | 2023-01-19 | — | — | WO | disclosed |